plasmid myc tagged egr1 (OriGene)
Structured Review

Plasmid Myc Tagged Egr1, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mr227136/Egr1+(NM_007913)+Mouse+Tagged+ORF+Clone/pmc08441070-115-0-4
Average 90 stars, based on 2 article reviews
Images
1) Product Images from "A mechanism of cooling hot tumors: Lactate attenuates inflammation in dendritic cells"
Article Title: A mechanism of cooling hot tumors: Lactate attenuates inflammation in dendritic cells
Journal: iScience
doi: 10.1016/j.isci.2021.103067
Figure Legend Snippet: Lactate (Lac) induces the expression of early growth response protein 1 (EGR1) (A) BMDCs from WT mice were stimulated with LPS (100 ng/mL) and/or Lac (20 mM) for 4 hr, and the total RNA from these cells was subjected to microarray analysis. The log2 ratios for the indicated genes in BMDCs stimulated with LPS plus Lac are arranged in descending order. (B) Western blot analysis of EGR1 expression in BMDCs stimulated with LPS (100 ng/mL) and/or Lac (20 mM) for 24 hr. (C) EGR1 expression (green) in RAW 264.7 cells stimulated with Lac (20 mM) or control medium (Ctrl) for 24 hr. Nuclei were stained with Hoechst 33,342 (blue). Scale bars = 10 μm. (D) Tumor tissues or control normal skin (Ctrl) from WT mice at two weeks after B16-F1 cell implantation were examined for EGR1 expression (green). Scale bars = 100 μm. (E) Median fluorescence intensity (MFI) of EGR1 in leukocyte subpopulations in tumor tissues of WT mice 3 weeks post-B16-F1 cell implantation was analyzed using flow cytometry. On days 6, 9 and 12 after injection of B16-F1 cells, Lac (5 mM, 200 μL) or PBS control (200 μL) was intratumorally administered. Data are expressed as mean ± SD. (F) The relationship between EGR1 MFI of tumor-infiltrating DCs and tumor weight (left) or lactate level (right) in the tumor tissues of WT mice 3–4 weeks post-B16-F1 cell implantation. Individual findings are plotted and each data point represents one mouse. Significance was analyzed using a two-tailed Student's t-test, Welch's t test, or Mann–Whitney's U test. Pearson's correlation coefficient was used to evaluate the correlations. ∗ p < 0.05; ∗∗ p < 0.01; n.s., not significant ( p > 0.05). See also and .
Techniques Used: Expressing, Microarray, Western Blot, Control, Staining, Fluorescence, Flow Cytometry, Injection, Two Tailed Test, MANN-WHITNEY
Figure Legend Snippet: EGR1 is expressed in DCs and correlates with LDHA in human melanoma tissues (A) Tumor tissues from patients with melanoma in situ and invasive melanoma were examined by fluorescent staining (Hoechst 33,342, blue), as well as by immunofluorescence analysis for EGR1 (green). Nuclei (enclosed within light blue lines) and EGR1-positive cells (enclosed within magenta lines) were counted automatically using the In Cell Analyzer software. Scale bars = 50 μm. (B) EGR1-positive ratios in tumor tissues of melanoma in situ and invasive melanoma are plotted (see also ). Each data point represents one patient. Bars indicate the mean. (C) Relationship between EGR1-positive ratio and tumor thickness (left) or serum 5-S-cysteinyl-DOPA (5-S-CD) levels (right). Individual findings are plotted and each data point represents one patient. (D) Primary tumor tissues from patients with invasive melanoma were examined by fluorescent staining as indicated. Scale bars = 50 μm. (E) Correlation analysis of EGR1 and LDHA expression levels using RNA-seq data set acquired from primary tumors from 45 skin cutaneous melanoma patients in TCGA (TCGA-SKCM). Significance was analyzed using a two-tailed Student's t-test, Welch's t test, or Mann–Whitney's U test. Pearson's correlation coefficient was used to evaluate the correlations. ∗ p < 0.05; ∗∗ p < 0.01.
Techniques Used: In Situ, Staining, Immunofluorescence, Software, Expressing, RNA Sequencing, Two Tailed Test, MANN-WHITNEY
Figure Legend Snippet: CD80 expression level is increased EGR1-deficient DCs (A) Levels of IL-12 p40, TNF-α, and IL-6 secreted by BMDCs stimulated with LPS (100 ng/mL) for 24 hr were measured by ELISA. Data are expressed as mean ± SD from two independent experiments (n = 3–5). (B) RNA from BMDCs from WT and Egr1 −/− mice was subjected to microarray analysis. The log2 ratio was determined for the corresponding genes categorized in cell adhesion molecules within KEGG pathways and the results were arranged in descending order. Genes that overlapped with TLR signaling pathways are in red boxes. (C) Flow cytometric analyses of CD80 and CD86 in CD11c + DCs within splenocytes from WT and Egr1 −/− mice. Representative plots are shown (left). Data are expressed as mean ± SD from two independent experiments (right, n = 3). MFI, median fluorescence intensity. (D) BMDCs from WT or Egr1 −/− mice were stimulated with LPS (100 ng/mL) and/or lactate (Lac, 20 mM) for 24 hr and the MFI of CD80 was assessed (n = 3). Data are expressed as mean ± SD. (E) CFSE-labeled CD8 + T cells from OT-I transgenic mice were co-cultured with BMDCs from WT or Egr1 −/− mice pulsed with Ova 257–264 peptide. Proliferation of OT-I CD8 + T cells was assessed after 72 hr by flow cytometry. (F and G) Tumor growth kinetics in WT or Egr1 −/− mice subcutaneously injected with 1 × 10 6 B16-F1 melanoma cells and treated with anti-PD-L1 antibody or control antibody (Ctrl), Lac and/or PBS as indicated. On days 6, 9, and 12 after injection of B16-F1 cells, 200 μg of control IgG Ab or anti-PD-L1 Ab were injected intraperitoneally (F), and Lac (5 mM, 200 μL) or PBS control (200 μL) was intratumorally administered (G). Data are shown as mean ± SD of 3–4 mice per group. (H) Tumor growth kinetics in diphtheria toxin (DTX)-treated CD11c-DTR bone marrow chimeric mice with subcutaneous injection with 1 × 10 6 B16-F1 melanoma cells and treated intratumorally with 1×10 6 WT or Egr1 −/− BMDCs. Data are shown as mean ± SD (n = 4 mice per group). Significance was analyzed using a two-tailed Student's t-test, Welch's t test, or Mann–Whitney's U test. ∗ p < 0.05; ∗∗ p < 0.01; n.s., not significant ( p > 0.05). See also and .
Techniques Used: Expressing, Enzyme-linked Immunosorbent Assay, Microarray, Protein-Protein interactions, Fluorescence, Labeling, Transgenic Assay, Cell Culture, Flow Cytometry, Injection, Control, Two Tailed Test, MANN-WHITNEY
Figure Legend Snippet: EGR1 interacts with SRF and may regulate its activation on the Cd80 promoter (A) ChIP-seq enrichment profiles for H3K27Ac at the Cd80 locus were generated using WT or Egr1 −/− BMDCs stimulated with LPS (100 ng/mL) and lactate (Lac, 20 mM) for 24 hr. (B) ChIP-seq enrichment profiles for EGR1 at the transcription start site (TSS) at the Cd80 locus were generated using WT BMDCs stimulated by LPS (100 ng/mL) and Lac (20 mM) for 24 hr. (C) The 3D protein structure of EGR1 and the EGR1 binding sequence from Protein DataBank were analyzed by CLC Genomics Workbench. (D) SRF was predicted as a potential transcription factor that binds to the region identified in (B) using TFBIND software. SRF was previously reported to interact with EGR1. TF, transcription factor. (E) ChIP-PCR analysis was performed using RAW 264.7 cells overexpressing Srf . ChIP was performed using control IgG (Ctrl) or anti-SRF antibody. PCR was performed using primers that detect sequences in the Cd80 promoter. (F) Co-immunoprecipitation experiments assessing EGR1 binding to SRF. Cell extracts from RAW 264.7 cells overexpressing both Srf and Myc-tagged Egr1 were immunoprecipitated with anti-SRF antibody or control IgG (Ctrl) and analyzed with anti-c-Myc and anti-SRF antibody by Western blotting. (G) Proposed schematic model of how lactate and its induction of EGR1 switches a hot tumor to a cold tumor. Lactate induces a shift from a hot tumor (presence of inflammation) to a cold (non-inflamed) tumor, while TLR4 ligands cause the opposite shift. Lactate upregulates the expression of EGR1, which may downregulate the expression of CD80. See also .
Techniques Used: Activation Assay, ChIP-sequencing, Generated, Binding Assay, Sequencing, Software, Control, Immunoprecipitation, Western Blot, Expressing
Figure Legend Snippet:
Techniques Used: Control, Recombinant, Isolation, Real-time Polymerase Chain Reaction, Enzyme-linked Immunosorbent Assay, Cell Isolation, Reporter Assay, Mutagenesis, Chromatin Immunoprecipitation, DNA Purification, Staining, Lactate Assay, Microarray, Negative Control, Plasmid Preparation, Software, Transfection
Related Articles
Plasmid Preparation:Article Title: A mechanism of cooling hot tumors: Lactate attenuates inflammation in dendritic cells Article Snippet: Plasmid: Egr1 , OriGene Technologies , MC217560. .. Plasmid: Myc-tagged Egr1 , OriGene Technologies , |
